C07J 5/00
Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17
Official title: Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, {i.e. only one oxygen bound to position 21 by a single bond}
C07J5/00 (Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17) appears on 433 US grants and 292 published applications in this corpus.
Search patents in C07J- Granted patents
- 433
- Published applications
- 292
- Assignees
- 191
- Inventors
- 772
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 12 | 0 |
| 1978 | 7 | 0 |
| 1979 | 7 | 0 |
| 1980 | 18 | 0 |
| 1981 | 17 | 0 |
| 1982 | 18 | 0 |
| 1983 | 5 | 0 |
| 1984 | 12 | 0 |
| 1985 | 10 | 0 |
| 1986 | 19 | 0 |
| 1987 | 8 | 0 |
| 1988 | 3 | 0 |
| 1989 | 8 | 0 |
| 1990 | 16 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 11 | 0 |
| 1996 | 12 | 0 |
| 1997 | 11 | 0 |
| 1998 | 9 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 1 |
| 2002 | 4 | 5 |
| 2003 | 5 | 12 |
| 2004 | 6 | 8 |
| 2005 | 4 | 12 |
| 2006 | 7 | 7 |
| 2007 | 4 | 10 |
| 2008 | 3 | 7 |
| 2009 | 0 | 5 |
| 2010 | 5 | 6 |
| 2011 | 4 | 2 |
| 2012 | 5 | 6 |
| 2013 | 2 | 16 |
| 2014 | 10 | 16 |
| 2015 | 8 | 12 |
| 2016 | 10 | 25 |
| 2017 | 15 | 19 |
| 2018 | 11 | 10 |
| 2019 | 18 | 14 |
| 2020 | 8 | 15 |
| 2021 | 7 | 16 |
| 2022 | 9 | 16 |
| 2023 | 9 | 14 |
| 2024 | 5 | 12 |
| 2025 | 10 | 14 |
| 2026 | 1 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Biotechnological optimization of microorganisms for the 1,2-dehydrogenation of steroids19 May 2026US 12,630,853 B2Euroapi France
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products18 Nov 2025US 12,473,247 B2
- Crystalline forms of dexamethasone dimers and uses thereof18 Nov 2025US 12,473,326 B2Ripple Therapeutics Corporation
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Non-hormonal steroid modulators of nf-kb for treatment of disease3 Sep 2026US 2026/0256810 A1ReveraGen BioPharma, Inc.
- Cocrystals of cortexolone 17-propionate and methods for their preparation6 Aug 2026US 2026/0226092 A1Farmabios S.P.A.
- Modified glucocorticoids30 Jul 2026US 2026/0217754 A1Board of Regents, The University of Texas System
- Process For The Production Of 21-(Acetyloxy)-17-(Propionyloxy)-Pregn-4-Ene-3,20-Dione4 Jun 2026US 2026/0152524 A1Industriale Chimica S.R.L.
Most cited
By later US patents
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Estrogenic compounds as anti-angiogenic agents112US 5,504,074 AChildren's Medical Center Corporation · 1996
- Micronised beclomethasone dipropionate monohydrate compositions and methods of use111US 4,866,051 AGlaxo Group Limited · 1989
- Liposomes containing steroid esters102US 4,693,999 AAktiebolaget Draco · 1987